Annexon Biosciences (ANNX) Gets a Buy from H.C. Wainwright

May 9, 2023 · In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Annexon Biosciences (ANNX – Research Report), with a price target of $30.00.The …

$30.00
OFF

Annexon Biosciences (ANNX) Gets A Buy From H.C. Wainwright

2 weeks from now

May 9, 2023 · In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Annexon Biosciences (ANNX – Research Report), with a price target of $30.00.The …

businessinsider.com

$30.00
OFF

Annexon (NASDAQ:ANNX) Given Buy Rating At HC Wainwright

2 weeks from now

Dec 17, 2024 · HC Wainwright restated a "buy" rating and set a $30.00 price target on shares of Annexon in a report on Tuesday. ... Annexon (NASDAQ:ANNX - Get Free Report) 's stock had …

marketbeat.com

$30.00
OFF

Annexon Shares Retain Buy Rating, Steady Target On Positive Topline ...

2 weeks from now

Dec 17, 2024 · On Tuesday, H.C. Wainwright maintained a Buy rating on shares of Annexon Biosciences (NASDAQ:ANNX), with a consistent price target of $30.00. The firm's …

investing.com

$30.00
OFF

New Data Supports BLA Package - Streetwisereports.com

2 weeks from now

In a December 17, 2024 research note, H.C. Wainwright & Co. analyst Andrew Fein maintained a Buy rating on Annexon Inc. (ANNX:NASDAQ) with a US$30.00 price target, following positive …

streetwisereports.com

$30.00
OFF

Annexon Shares Positive On ARCHER Trial Data, Analyst Maintains …

2 weeks from now

Oct 23, 2024 · H.C. Wainwright also maintained its buy rating and $30.00 price target for Annexon, based on projected earnings per share and discounted cash flow analysis. …

investing.com

$30.00
OFF

H.C. Wainwright Weighs ANX005 Risks For Annexon Biosciences, …

2 weeks from now

Aug 13, 2024 · The reiteration of the Buy rating and the $30.00 price target comes as Annexon Biosciences continues to progress in its clinical development efforts, with ANX005 at the …

investing.com

88%
OFF

Annexon (ANNX) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

3 days ago · HC Wainwright. 2 of 5 stars : Reiterated Rating: Buy Buy: $30.00 $30.00 +492.88%: 11/15/2024: ... The consensus among Wall Street equities research analysts is that investors …

marketbeat.com

$30.00
OFF

Promising Outlook For Annexon’s ANX005 In GBS Treatment: A ...

2 weeks from now

Mar 4, 2024 · Andrew Fein, an analyst from H.C. Wainwright, reiterated the Buy rating on Annexon Biosciences (ANNX – Research Report).The associated price target is $30.00. …

businessinsider.com

$3.86
OFF

Barclays PLC Acquires 120,789 Shares Of Annexon, Inc.

2 weeks from now

16 hours ago · Annexon, Inc. has a 1 year low of $3.86 and a 1 year high of $8.40. Wall Street Analysts Forecast Growth. A number of equities analysts have weighed in on the company. …

marketbeat.com

FAQs about Annexon Biosciences (ANNX) Gets a Buy from H.C. Wainwright Coupon?

Does HC Wainwright reissue a Buy rating on Annexon (annx)?

HC Wainwright reissued their buy rating on shares of Annexon (NASDAQ:ANNX – Free Report) in a research note published on Tuesday, Benzinga reports. They currently have a $30.00 price target on the stock. ANNX has been the subject of several other reports. ...

Is Annexon Biosciences a good buy?

Currently, the analyst consensus on Annexon Biosciences is a Strong Buy with an average price target of $21.00, which is a 300.00% upside from current levels. In a report released yesterday, BTIG also maintained a Buy rating on the stock with a $15.00 price target. ...

Does Charles Schwab own Annexon?

Charles Schwab Investment Management Inc. raised its holdings in shares of Annexon by 221.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 732,216 shares of the company’s stock worth $4,335,000 after buying an additional 504,656 shares during the last quarter. ...